OXALTIN 50 MG

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

OXALIPLATIN 50 MG

Mevcut itibaren:

PERRIGO ISRAEL AGENCIES LTD

ATC kodu:

L01XA03

Farmasötik formu:

POWDER FOR SOLUTION FOR INFUSION

Uygulama yolu:

I.V

Tarafından üretildi:

ACTAVIS ITALY S.P.A

Terapötik grubu:

OXALIPLATIN

Terapötik endikasyonlar:

Oxaliplatin in combination with 5-fluorouracil (5-FU) and folinic acid (FA) is indicated for:- Adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of primary tumour.-Treatment of metastatic colorectal cancer.

Yetkilendirme tarihi:

2013-08-01